Dana-Farber oncologists present at ASCO GU -- predict prostate cancer survival using Source MDx test
Dana-Farber Cancer Institute (DFCI) and Source MDx today announced that Source MDx's whole blood RNA transcript-based Precision Profiles(TM) diagnostic test…
Feb 27, 2009